Contact
Please use this form to send email to PR contact of this press release:
Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome
TO:
Please use this form to send email to PR contact of this press release:
Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome
TO: